Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ji-Tao Wei"'
Publikováno v:
OncoTargets and therapy
Junqing Li,1,2,* Wenjie Zhou,1,2,* Jitao Wei,3 Xing Xiao,3 Tailai An,1 Wenhui Wu,1 Yulong He1,2 1Digestive Disease Center, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518000, People’s Republic of China; 2Department of Gastrointes
Autor:
Xiao-Fang Lu, Bo Li, Changhua Zhang, Zhewei Wei, Xing Xiao, Ji-Tao Wei, Wei-Wei Chu, Tengfei Hao, Yulong He, Hong Chen, Sijun Meng, Wei Chen
Publikováno v:
OncoTargets and Therapy. 13:6017-6025
Background Nab-paclitaxel has been widely used in treating breast cancer and pancreatic patients for its low toxicity and high efficiency. However, its role in gastric cancer (GC) remains ambiguous. The aim of our study was to test the anti-tumor act
Autor:
Sheng-Lei Song, Bo Li, Mariana R. Carvalho, Hui-Jin Wang, De-Li Mao, Ji-Tao Wei, Wei Chen, Zhi-Hui Weng, Yang-Chao Chen, Chu-Xia Deng, Rui L. Reis, Joaquim M. Oliveira, Yu-Long He, Le-Ping Yan, Chang-Hua Zhang
Publikováno v:
Pharmacology & Therapeutics. 239:108276
Digestive system cancers account for nearly half of all cancers around the world and have a high mortality rate. Cell culture and animal models represent cornerstones of digestive cancer research. However, their ability to en- able cancer precision m
Autor:
Xing, Xiao, Wei, Chen, Zhe-Wei, Wei, Wei-Wei, Chu, Xiao-Fang, Lu, Bo, Li, Hong, Chen, Si-Jun, Meng, Teng-Fei, Hao, Ji-Tao, Wei, Yu-Long, He, Chang-Hua, Zhang
Publikováno v:
OncoTargets and therapy
Background Nab-paclitaxel has been widely used in treating breast cancer and pancreatic patients for its low toxicity and high efficiency. However, its role in gastric cancer (GC) remains ambiguous. The aim of our study was to test the anti-tumor act